Albumin-Bilirubin Grade as a Three-Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Transarterial Chemoembolization (ALBI Grade Predicting Survival in HCC Treated With TACE)

Ummi Maimunah and Andri Pramana Restu and Iswan Abbas Nusi and Herry Purbayu and Titong Sugihartono and Ulfa Kholili and Budi Widodo and Muhammad Miftahussurur and Husin Thamrin and Amie Vidyani and Poernomo Boedi Setiawan (2020) Albumin-Bilirubin Grade as a Three-Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Transarterial Chemoembolization (ALBI Grade Predicting Survival in HCC Treated With TACE). Systematic Reviews in Pharmacy, 11 (5). pp. 205-208. ISSN 0975-8453

[img] Text (Artikel)
28. Albumin-bilirubin grade as a three-month survival predictor in hepatocellular carcinoma patients after initial transarterial che.pdf
Download (398kB)
[img] Text (Peer Review)
28. Albumin-bilirubin grade as a three-month survival predictor in hepatocellular carcinoma patients after initial transa.pdf
Download (855kB)
[img] Text (Similarity)
28. Albumin-bilirubin grade as a three-month survival predictor in hepatocellular carcinoma patients after initial transarterial che.pdf
Download (1MB)
Official URL: https://www.sysrevpharm.org/abstract/albuminbiliru...

Abstract

One of hepatocellular carcinoma (HCC) therapeutic modality is transarterial chemoembolization (TACE). The albumin-bilirubin (ALBI) grade is amongst the newest of prognostic scores published to predict survival. The aim of this study was to analzye the ALBI grade as a three-month survival predictor in HCC patients after initial TACE. This was a retrospective analytic observational study identifying patients that underwent initial TACE from January 2013 to December 2017 in Dr. Soetomo General Hospital, Surabaya. Data were collected before treatment and analyzed to evaluate ALBI grade as a survival predictor. Out of 134 HCC patients, the subjects consisted of 100 (74.6%) male subjects and 34 (25.4%) female subjects. There were 25 (18.7%), 98 (73.1%), dan 11 (8.2%) subjects who were classified into to ALBI 1, ALBI 2, and ALBI 3, respectively, with a median ALBI score of -2.295. The ALBI grade was significantly associated with the three-month survival variable (p = 0.01; CI 95%). Using the ROC curve, we have determined a new cut-off point. The group of ALBI score ≤ -2.27 had an odds ratio of 2.549 (CI 95% 1.232-5.273) for three-month survival. The ALBI grade was associated with three-month survival after initial TACE in patients with HCC.

Item Type: Article
Uncontrolled Keywords: HCC, TACE, ALBI grade, survival
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine
Divisions: 01. Fakultas Kedokteran > Ilmu Penyakit Dalam
Creators:
CreatorsNIM
Ummi MaimunahNIDN8896900016
Andri Pramana RestuUNSPECIFIED
Iswan Abbas NusiNIDN0028025003
Herry PurbayuNIDN8884800016
Titong SugihartonoNIDN8836800016
Ulfa KholiliNIDN0004047511
Budi WidodoNIDN8804800016
Muhammad MiftahussururNIDN0029097909
Husin ThamrinNIDN8825800016
Amie VidyaniNIDN0028018002
Poernomo Boedi SetiawanNIDN8886900016
Depositing User: arys fk
Date Deposited: 19 Jul 2021 07:02
Last Modified: 19 Jul 2021 07:02
URI: http://repository.unair.ac.id/id/eprint/108624
Sosial Share:

Actions (login required)

View Item View Item